Back to search

Article

TMPRSS2 Transcriptional Inhibition as a Therapeutic Strategy for COVID-19 <strong> </strong>

2020-04-28

Abstract excerpt

There is an urgent need to identify effective therapies for COVID-19. The SARS-CoV-2 host factor protease TMPRSS2 is required for viral entry and thus an attractive target for therapeutic intervention. In mouse, knockout of tmprss2 led to protection against SARS-CoV-1 with no deleterious phenotypes, and in human populations genetic loss of TMPRSS2 does not appear to be selected against. Here, we mined publicly ava...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5c150204-e8d8-577c-93ab-80180cab74d9
DOI
10.20944/preprints202003.0360.v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TMPRSS2 Transcriptional Inhibition as a Therapeutic Strategy for COVID-19 <strong> </strong>DOI 10.20944/preprints202003.0360.v2
Select a neighboring publication to make it the new centre.